Toulouse, France

Paul M De Cointet

This inventor holds 1 USPTO granted patent. Top assignee: Centre National De La Recherche Scientifique. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul M De Cointet. Retrieved from https://idiyas.com/inventor/paul-m-de-cointet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Paul M De Cointet: Innovator in Pharmaceutical Compounds

Introduction

Paul M De Cointet is a notable inventor based in Toulouse, France. He has made significant contributions to the field of pharmaceuticals through his innovative research and development. His work focuses on the synthesis of new compounds that have potential applications in the pharmaceutical industry.

Latest Patents

One of his key patents is for 1,2-dihydro-4-methyl-1-oxo-5H-pyrido(4,3-b)indoles. This invention relates to new compounds represented by the formula (I), where R can be hydrogen or an alkoxy or aryl carbonyloxy group. These compounds serve as intermediates in the synthesis of pharmaceuticals, highlighting their importance in drug development.

Career Highlights

Paul M De Cointet is associated with Sanofi and the Centre National De La Recherche Scientifique. His work at these institutions has allowed him to explore and develop innovative solutions in the pharmaceutical sector. He holds a total of 1 patent, showcasing his contributions to the field.

Collaborations

Throughout his career, Paul has collaborated with esteemed colleagues such as Emile R Bisagni and Hung C Nguyen. These partnerships have further enriched his research and development efforts.

Conclusion

Paul M De Cointet is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the industry significantly. His innovative spirit and collaborative efforts continue to drive advancements in drug synthesis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…